Effective pressure and treatment duration of high hydrostatic pressure to prepare melanoma vaccines.
HHP
effective pressure
immunogenicity
melanoma vaccine
treatment duration
Journal
Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
15
10
2019
accepted:
06
04
2020
entrez:
30
7
2020
pubmed:
30
7
2020
medline:
30
7
2020
Statut:
ppublish
Résumé
Current therapeutic methods for melanoma have numerous limitations, and thus the improvement of such treatment methods are essential. One possible option is the vaccination of autologous inactivated tumor cells. The primary indispensable principles of a cell-based melanoma vaccine include: i) Entire inactivation of melanoma cells; ii) retaining the immunogenicity of melanoma cells; and iii) adherence to laws and ethical guidelines. However, traditional methods for the production of the vaccine, such as ultrasonic, chemotherapeutics and freeze-thawing, have some juridical or therapeutic constraints. Therefore, the present study used high hydrostatic pressure (HHP) to inactivate malignant cells, and treated B16-F10 tumor cells with different pressures (≥50 MPa) and different durations (≥1 min). It was identified that tumor cells
Identifiants
pubmed: 32724353
doi: 10.3892/ol.2020.11657
pii: OL-0-0-11657
pmc: PMC7377178
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1135-1142Informations de copyright
Copyright: © Liu et al.
Références
J Am Chem Soc. 2019 Sep 4;141(35):13762-13766
pubmed: 31432672
Int J Cancer. 2000 Jun 1;86(5):725-30
pubmed: 10797297
J Food Prot. 2009 Jul;72(7):1500-8
pubmed: 19681278
Best Pract Res Clin Haematol. 2008 Sep;21(3):559-77
pubmed: 18790455
Biosci Biotechnol Biochem. 2012;76(1):53-9
pubmed: 22232242
Apoptosis. 2009 Apr;14(4):364-75
pubmed: 19145485
J Microbiol Biotechnol. 2019 Aug 28;29(8):1240-1247
pubmed: 31370118
Cell Mol Biol (Noisy-le-grand). 2004 Jun;50(4):469-77
pubmed: 15529756
Tumori. 2019 Dec;105(6):465-473
pubmed: 31446882
Anticancer Res. 2008 Nov-Dec;28(6B):3877-83
pubmed: 19192644
Int J Food Microbiol. 2016 Apr 16;223:17-24
pubmed: 26874862
PLoS One. 2017 Aug 16;12(8):e0183226
pubmed: 28813497
J Clin Invest. 2015 Sep;125(9):3401-12
pubmed: 26214521
JCI Insight. 2017 Apr 20;2(8):
pubmed: 28422751
World J Surg. 2001 Feb;25(2):210-7
pubmed: 11338024
Vaccine. 2007 Sep 27;25 Suppl 2:B35-46
pubmed: 17916462
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Nov;58(11-12):1254-8
pubmed: 26349562
J Control Release. 2016 Apr 28;228:26-37
pubmed: 26921522
Cancer Immunol Immunother. 2008 Oct;57(10):1569-77
pubmed: 18523771
J Control Release. 2016 Jun 10;231:17-28
pubmed: 26829099
J Immunotoxicol. 2009 Dec;6(4):209-16
pubmed: 19908939
J Appl Microbiol. 2005;98(6):1400-9
pubmed: 15916652
Cell Mol Biol (Noisy-le-grand). 2004 Jun;50(4):459-67
pubmed: 15529755
Immunol Lett. 2017 Jul;187:27-34
pubmed: 28495513
Nanomedicine. 2010 Aug;6(4):523-9
pubmed: 20085824
Front Oncol. 2012 Oct 09;2:132
pubmed: 23087898
Cell Mol Biol (Noisy-le-grand). 2004 Jun;50(4):397-417
pubmed: 15529750
Curr Opin Biotechnol. 2007 Feb;18(1):17-25
pubmed: 17234399
Biochim Biophys Acta. 2002 Mar 25;1595(1-2):235-49
pubmed: 11983399
J Immunotoxicol. 2010 Jul-Sep;7(3):194-204
pubmed: 20205624
Cancer Control. 2014 Jul;21(3):231-7
pubmed: 24955707
Eur J Biochem. 1994 Apr 15;221(2):617-30
pubmed: 8174542
Biochim Biophys Acta. 2002 Mar 25;1595(1-2):160-84
pubmed: 11983394
Sci Rep. 2019 Jul 25;9(1):10814
pubmed: 31346207
NPJ Vaccines. 2019 Feb 8;4:7
pubmed: 30774998
Foods. 2019 Aug 01;8(8):
pubmed: 31374950
Sci Rep. 2017 Apr 06;7:46034
pubmed: 28382948
Nat Rev Clin Oncol. 2016 May;13(5):273-90
pubmed: 26977780
Biosci Biotechnol Biochem. 2017 Apr;81(4):672-679
pubmed: 28300504
Cancer Immunol Immunother. 2016 Mar;65(3):327-39
pubmed: 26861670
Oncol Lett. 2018 Apr;15(4):5345-5351
pubmed: 29552177
Int J Cancer. 2014 Sep 1;135(5):1165-77
pubmed: 24500981
Curr Pharm Des. 2004;10(30):3797-811
pubmed: 15579072
Autoimmunity. 2007 Jun;40(4):254-9
pubmed: 17516206
Front Oncol. 2019 Aug 28;9:805
pubmed: 31555582
Semin Cancer Biol. 2019 Dec;59:283-289
pubmed: 31445219
Vet Immunol Immunopathol. 2019 Oct;216:109912
pubmed: 31446208
Food Chem. 2016 Jul 15;203:258-266
pubmed: 26948613